Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis NONOF

Max Ratio

14.26

Dividend Yield

2.71 %

5Y Dividend Growth

160.00 %

Consecutive Years

6 years

5Y Average Payout Ratio

46.03 %

Dividend History NONOF

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 2.71 %
Consecutive Years 6
Forward Annual Dividend 1.69 USD
Consistent Years 6
Dividend CAGR 3Y 23.40 %
Continuous Dividends
Dividend CAGR 5Y 20.69 %
Payout Ratio TTM 0.11 %
Dividend CAGR 10Y 13.79 %
Ex Dividend Date 09/18/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth NONOF

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin NONOF

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income NONOF

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM NONOF

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio NONOF

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Novo Nordisk A/S NONOF

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself NONOF

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 17.17
Forward PE 17.48
Enterprise Value Revenue 5.69
Price Sales TTM 0.88
Enterprise Value EBITDA 11.90
Price Book MRQ 10.49

Novo Nordisk A/S Dividends: 2.71 % Yield, History, Payment Schedule

NONOF
Current price
62.25 USD +5.25 USD (+9.21%)
Last closed 57.12 USD
ISIN US6701002056
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NYSE
Capitalization 276 962 082 816 USD
Yield for 12 month -23.08 %
1Y
3Y
5Y
10Y
15Y
NONOF
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+45 186 272 415 USD

Last Year

+36 139 464 184 USD

Current Quarter

+11 666 153 451 USD

Last Quarter

+11 958 834 237 USD

Current Year

+38 258 715 811 USD

Last Year

+30 574 483 681 USD

Current Quarter

+8 880 317 832 USD

Last Quarter

+9 960 015 852 USD
EBITDA 165 492 998 144 USD
Operating Margin TTM 44.35 %
Price to Earnings 17.17
Return On Assets TTM 21.11 %
PEG Ratio 2.68
Return On Equity TTM 71.47 %
Wall Street Target Price 55.88 USD
Revenue TTM 315 602 993 152 USD
Book Value 5.94 USD
Revenue Per Share TTM
Dividend Share 11.65 USD
Quarterly Revenue Growth YOY 5.10 %
Dividend Yield 2.71 %
Gross Profit TTM 263 334 002 688 USD
Earnings per share 3.63 USD
Diluted Eps TTM 3.63 USD
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY -26.50 %
Profit Margin 32.88 %

Technical Indicators NONOF

For 52 Weeks

43.08 USD 91.28 USD
50 Day MA 50.62 USD
Shares Short Prior Month 29 593 438
200 Day MA 59.01 USD
Short Ratio 2.04
Shares Short 32 384 787
Short Percent 0.96 %